Surgical Decision Making in the BRCA-Positive Population: Institutional Experience and Comparison with Recent Literature

Medical Mistrust Influences Black Women’s Level of Engagement in BRCA1/2 Genetic Counseling and Testing

(2015) Vanessa B. Sheppard et al.   JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION

Impact of Oophorectomy on Cancer Incidence and Mortality in Women With a BRCA1 or BRCA2 Mutation

(2014) Amy P.M. Finch et al.   JOURNAL OF CLINICAL ONCOLOGY

A rapid genetic counselling and testing in newly diagnosed breast cancer is associated with high rate of risk-reducing mastectomy in BRCA1/2-positive Italian women

(2013) L. Cortesi et al.   ANNALS OF ONCOLOGY

Risk management options elected by women after testing positive for a BRCA mutation

(2013) Christine Garcia et al.   GYNECOLOGIC ONCOLOGY

Oral Contraceptives and Risk of Ovarian Cancer and Breast Cancer Among High-Risk Women: A Systematic Review and Meta-Analysis

(2013) Patricia G. Moorman et al.   JOURNAL OF CLINICAL ONCOLOGY

Tamoxifen and Risk of Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers

(2013) Kelly-Anne Phillips et al.   JOURNAL OF CLINICAL ONCOLOGY

Cancer Risks for BRCA1 and BRCA2 Mutation Carriers: Results From Prospective Analysis of EMBRACE

(2013) Nasim Mavaddat et al.   JNCI-Journal of the National Cancer Institute

Reduction in rate of node metastases with breast screening: consistency of association with tumor size

(2012) I. D. Nagtegaal et al.   BREAST CANCER RESEARCH AND TREATMENT

Detection of Breast Cancer With Addition of Annual Screening Ultrasound or a Single Screening MRI to Mammography in Women With Elevated Breast Cancer Risk

(2012) Zheng Zhang   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Factors Associated with Psychological Distress among Women of African Descent at High Risk for BRCA Mutations

(2012) Yael R. Cukier et al.   Journal of Genetic Counseling

Long-term outcomes ofBRCA1/BRCA2testing: risk reduction and surveillance

(2011) Marc D. Schwartz et al.   CANCER

Oral contraceptives and risk of ovarian and breast cancers inBRCAmutation carriers: a meta-analysis

(2011) David Cibula et al.   Expert Review of Anticancer Therapy

Prospective Study of Breast Cancer Incidence in Women With aBRCA1orBRCA2Mutation Under Surveillance With and Without Magnetic Resonance Imaging

(2011) Ellen Warner et al.   JOURNAL OF CLINICAL ONCOLOGY

Comparative effectiveness of screening and prevention strategies among BRCA1/2-affected mutation carriers

(2010) Victor R. Grann et al.   BREAST CANCER RESEARCH AND TREATMENT

Risk-reducing mastectomy and salpingo-oophorectomy in unaffected BRCA mutation carriers: uptake and timing

(2010) A-B Skytte et al.   CLINICAL GENETICS

Association of Risk-Reducing Surgery in BRCA1 or BRCA2 Mutation Carriers With Cancer Risk and Mortality

(2010) Susan M. Domchek   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Choice of Management of Southern Chinese BRCA Mutation Carriers

(2010) Ava Kwong et al.   WORLD JOURNAL OF SURGERY

Uptake, Time Course, and Predictors of Risk-Reducing Surgeries in BRCA Carriers

(2009) Mary S. Beattie et al.   Genetic Testing and Molecular Biomarkers

Estimated Risk of Radiation-Induced Breast Cancer From Mammographic Screening for Young BRCA Mutation Carriers

(2009) A. Berrington de Gonzalez et al.   JNCI-Journal of the National Cancer Institute

International variation in rates of uptake of preventive options in BRCA1 and BRCA2 mutation carriers

(2008) Kelly A. Metcalfe et al.   INTERNATIONAL JOURNAL OF CANCER